EXTENDED - TODAY ONLY: MarketBeat All Access For Just $399 $199 (save 50%)
Special Offer: Just $199
×
S&P 500   3,955.06 (-0.22%)
DOW   33,825.53 (-0.07%)
QQQ   280.46 (-0.80%)
AAPL   140.72 (-2.43%)
MSFT   240.09 (-0.69%)
META   109.97 (+1.09%)
GOOGL   95.32 (-0.76%)
AMZN   92.41 (-1.64%)
TSLA   180.35 (-1.40%)
NVDA   156.31 (-1.24%)
NIO   10.51 (+3.85%)
BABA   79.91 (+5.31%)
AMD   73.42 (+0.31%)
T   18.92 (+0.53%)
MU   54.89 (-1.54%)
CGC   3.43 (+0.88%)
F   13.73 (+0.00%)
GE   85.66 (+0.22%)
DIS   94.37 (-1.38%)
AMC   7.43 (+1.36%)
PYPL   77.98 (-2.44%)
PFE   49.42 (-0.30%)
NFLX   280.65 (-0.18%)
S&P 500   3,955.06 (-0.22%)
DOW   33,825.53 (-0.07%)
QQQ   280.46 (-0.80%)
AAPL   140.72 (-2.43%)
MSFT   240.09 (-0.69%)
META   109.97 (+1.09%)
GOOGL   95.32 (-0.76%)
AMZN   92.41 (-1.64%)
TSLA   180.35 (-1.40%)
NVDA   156.31 (-1.24%)
NIO   10.51 (+3.85%)
BABA   79.91 (+5.31%)
AMD   73.42 (+0.31%)
T   18.92 (+0.53%)
MU   54.89 (-1.54%)
CGC   3.43 (+0.88%)
F   13.73 (+0.00%)
GE   85.66 (+0.22%)
DIS   94.37 (-1.38%)
AMC   7.43 (+1.36%)
PYPL   77.98 (-2.44%)
PFE   49.42 (-0.30%)
NFLX   280.65 (-0.18%)
S&P 500   3,955.06 (-0.22%)
DOW   33,825.53 (-0.07%)
QQQ   280.46 (-0.80%)
AAPL   140.72 (-2.43%)
MSFT   240.09 (-0.69%)
META   109.97 (+1.09%)
GOOGL   95.32 (-0.76%)
AMZN   92.41 (-1.64%)
TSLA   180.35 (-1.40%)
NVDA   156.31 (-1.24%)
NIO   10.51 (+3.85%)
BABA   79.91 (+5.31%)
AMD   73.42 (+0.31%)
T   18.92 (+0.53%)
MU   54.89 (-1.54%)
CGC   3.43 (+0.88%)
F   13.73 (+0.00%)
GE   85.66 (+0.22%)
DIS   94.37 (-1.38%)
AMC   7.43 (+1.36%)
PYPL   77.98 (-2.44%)
PFE   49.42 (-0.30%)
NFLX   280.65 (-0.18%)
S&P 500   3,955.06 (-0.22%)
DOW   33,825.53 (-0.07%)
QQQ   280.46 (-0.80%)
AAPL   140.72 (-2.43%)
MSFT   240.09 (-0.69%)
META   109.97 (+1.09%)
GOOGL   95.32 (-0.76%)
AMZN   92.41 (-1.64%)
TSLA   180.35 (-1.40%)
NVDA   156.31 (-1.24%)
NIO   10.51 (+3.85%)
BABA   79.91 (+5.31%)
AMD   73.42 (+0.31%)
T   18.92 (+0.53%)
MU   54.89 (-1.54%)
CGC   3.43 (+0.88%)
F   13.73 (+0.00%)
GE   85.66 (+0.22%)
DIS   94.37 (-1.38%)
AMC   7.43 (+1.36%)
PYPL   77.98 (-2.44%)
PFE   49.42 (-0.30%)
NFLX   280.65 (-0.18%)
NYSE:TFX

Teleflex - TFX Stock Forecast, Price & News

$227.62
+3.13 (+1.39%)
(As of 11/29/2022 03:33 PM ET)
Add
Compare
Today's Range
$224.53
▼
$228.16
50-Day Range
$186.76
▼
$225.71
52-Week Range
$182.65
▼
$356.72
Volume
16,158 shs
Average Volume
341,791 shs
Market Capitalization
$10.68 billion
P/E Ratio
26.10
Dividend Yield
0.60%
Price Target
$271.46

Teleflex MarketRank™ Forecast

Analyst Rating
Hold
2.46 Rating Score
Upside/​Downside
19.4% Upside
$271.46 Price Target
Short Interest
Healthy
2.96% of Shares Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
-1.53
Upright™ Environmental Score
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
4.47%
From $12.98 to $13.56 Per Share

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.58 out of 5 stars

Medical Sector

138th out of 1,038 stocks

Surgical & Medical Instruments Industry

18th out of 103 stocks

See Top Rated MarketRank™ Stocks Here
TFX stock logo

About Teleflex (NYSE:TFX) Stock

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. The company also offers interventional products, which consists of various coronary catheters, structural heart therapies, and peripheral intervention and cardiac assist products that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded catheters, Guideline and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. It provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. The company also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; and respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings. It provides urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. The company was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.

Receive TFX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Teleflex and its competitors with MarketBeat's FREE daily newsletter.

TFX Stock News Headlines

November 28, 2022 | forbes.com
Should You Buy Teleflex Stock At $225?
November 21, 2022 | finance.yahoo.com
Teleflex Earns Top Spot in MedReps Best Places to Work 2023 Ranking
November 16, 2022 | finance.yahoo.com
Teleflex to Present at the 34th Annual Piper Sandler Healthcare Conference
November 7, 2022 | finance.yahoo.com
Insiders who purchased Teleflex Incorporated (NYSE:TFX) earlier this year lose an additional US$105k as the stock sinks to US$202
November 7, 2022 | markets.businessinsider.com
Teleflex Expands Recalls Of Gibeck Iso-Gard Filters
November 3, 2022 | finance.yahoo.com
Teleflex Announces Worldwide Recall of Gibeck® Iso-Gard® Filter
November 2, 2022 | finance.yahoo.com
Teleflex Recalls Respiratory Filters Due To Leakage, Insufficient Air Supply Risk
November 1, 2022 | finance.yahoo.com
Teleflex (TFX) Q3 Earnings Top Estimates, Adjusted EPS View Cut
November 1, 2022 | finance.yahoo.com
U.S. FDA classifies recall of Teleflex's respiratory filters as most serious
November 1, 2022 | finance.yahoo.com
Teleflex to Present at the Jefferies London Healthcare Conference
October 27, 2022 | finance.yahoo.com
Teleflex (TFX) Surpasses Q3 Earnings Estimates
October 25, 2022 | seekingalpha.com
Teleflex: More Constructive Following Recent Weakness, Valuations Noteworthy
October 25, 2022 | finance.yahoo.com
Should You Sell Teleflex Incorporated (TFX)?
October 20, 2022 | finance.yahoo.com
Teleflex (TFX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
October 13, 2022 | benzinga.com
Teleflex Announces Third Quarter 2022 Earnings Conference Call Information - Teleflex (NYSE:TFX) - Benzinga
October 13, 2022 | finance.yahoo.com
Teleflex Announces Third Quarter 2022 Earnings Conference Call Information
October 10, 2022 | globenewswire.com
Insights on the Gastrointestinal Endoscopy Global Market to 2031 - Featuring Boston Scientific, Medtronic, Ambu and Teleflex Among Others - GlobeNewswire
October 10, 2022 | finance.yahoo.com
Standard Bariatrics $300M sale complete; exit stands among top three largest in Cincinnati region
October 7, 2022 | nasdaq.com
Teleflex Incorporated Shares Fall 0.2% Below Previous 52-Week Low - Market Mover - Nasdaq
September 28, 2022 | markets.businessinsider.com
Teleflex Releases New Arrow Pressure Injectable Midline Catheter Portfolio In US, Canada
September 28, 2022 | finance.yahoo.com
Teleflex Completes Acquisition of Standard Bariatrics
September 27, 2022 | globenewswire.com
Teleflex launches new Arrow® Pressure Injectable Midline Catheter Portfolio - GlobeNewswire
September 27, 2022 | finance.yahoo.com
Teleflex launches new Arrow® Pressure Injectable Midline Catheter Portfolio
September 26, 2022 | globenewswire.com
Anesthesia & Respiratory Devices Market Size Will Attain USD 49.9 Billion by 2030 growing at 6.5% CAGR - Exclusive Report by Acumen Research and Consulting - GlobeNewswire
September 26, 2022 | businesswire.com
Insights on the Flowable Hemostats Global Market to 2028 - Featuring Baxter International, Teleflex and Pfizer Among Others - ResearchAndMarkets.com - Business Wire
See More Headlines
Receive TFX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Teleflex and its competitors with MarketBeat's FREE daily newsletter.

TFX Company Calendar

Ex-Dividend for 9/15 Dividend
8/12/2022
Dividend Payable
9/15/2022
Last Earnings
10/27/2022
Ex-Dividend for 12/15 Dividend
11/14/2022
Today
11/29/2022
Dividend Payable
12/15/2022
Fiscal Year End
12/31/2022
Next Earnings (Estimated)
2/23/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Surgical & medical instruments
Sub-Industry
Health Care Equipment
Sector
Medical
Current Symbol
NYSE:TFX
CUSIP
87936910
CIK
96943
Web
www.teleflex.com
Phone
(610) 225-6800
Fax
215-553-5402
Employees
14,000
Year Founded
1943

Price Target and Rating

Average Stock Price Forecast
$271.46
High Stock Price Forecast
$400.00
Low Stock Price Forecast
$210.00
Forecasted Upside/Downside
+19.3%
Consensus Rating
Hold
Rating Score (0-4)
2.46
Research Coverage
13 Analysts

Profitability

EPS (Most Recent Fiscal Year)
$8.72
Trailing P/E Ratio
26.10
Forward P/E Ratio
17.54
P/E Growth
2.66
Net Income
$485.37 million
Net Margins
14.76%
Pretax Margin
17.17%
Return on Equity
16.26%
Return on Assets
9.14%

Debt

Debt-to-Equity Ratio
0.41
Current Ratio
2.39
Quick Ratio
1.52

Sales & Book Value

Annual Sales
$2.81 billion
Price / Sales
3.80
Cash Flow
$18.83 per share
Price / Cash Flow
12.09
Book Value
$80.15 per share
Price / Book
2.84

Miscellaneous

Outstanding Shares
46,910,000
Free Float
46,306,000
Market Cap
$10.68 billion
Optionable
Optionable
Beta
1.09

Social Links


Key Executives

  • Mr. Liam J. KellyMr. Liam J. Kelly (Age 55)
    Chairman, Pres & CEO
    Comp: $3.01M
  • Mr. Thomas E. Powell (Age 60)
    Exec. VP & CFO
    Comp: $1.44M
  • Mr. Cameron P. HicksMr. Cameron P. Hicks (Age 57)
    Corp. VP & Chief HR Officer
    Comp: $771.45k
  • Mr. Jay White (Age 48)
    Corp. VP & Pres of Global Commercial
    Comp: $1.23M
  • Mr. James P. Winters
    Corp. VP, Manufacturing and Supply Chain
  • Mr. John R. Deren
    Corp. VP & Chief Accounting Officer
  • Mr. John Hsu C.F.A.
    VP of Investor Relations
  • Mr. Daniel V. Logue (Age 48)
    Corp. VP, Gen. Counsel & Sec.
  • Mr. Howard Cyr
    Corp. VP & Chief Compliance Officer
  • Mr. Matt Tomkin
    VP of Corp. Devel.

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions













TFX Stock - Frequently Asked Questions

Should I buy or sell Teleflex stock right now?

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Teleflex in the last year. There are currently 7 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" TFX shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in TFX, but not buy additional shares or sell existing shares.
View TFX analyst ratings or view top-rated stocks.

What is Teleflex's stock price forecast for 2023?

13 Wall Street analysts have issued 1-year price targets for Teleflex's shares. Their TFX share price forecasts range from $210.00 to $400.00. On average, they expect the company's share price to reach $271.46 in the next twelve months. This suggests a possible upside of 19.0% from the stock's current price.
View analysts price targets for TFX or view top-rated stocks among Wall Street analysts.

How have TFX shares performed in 2022?

Teleflex's stock was trading at $328.48 at the start of the year. Since then, TFX stock has decreased by 30.6% and is now trading at $228.08.
View the best growth stocks for 2022 here.

When is Teleflex's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 23rd 2023.
View our TFX earnings forecast.

How were Teleflex's earnings last quarter?

Teleflex Incorporated (NYSE:TFX) released its quarterly earnings data on Thursday, October, 27th. The medical technology company reported $3.27 EPS for the quarter, topping analysts' consensus estimates of $3.11 by $0.16. The medical technology company had revenue of $686.80 million for the quarter, compared to analysts' expectations of $691.52 million. Teleflex had a net margin of 14.76% and a trailing twelve-month return on equity of 16.26%. The business's revenue for the quarter was down 1.9% compared to the same quarter last year. During the same period in the previous year, the firm earned $3.51 earnings per share.
Read the conference call transcript.

How often does Teleflex pay dividends? What is the dividend yield for Teleflex?

Teleflex announced a quarterly dividend on Thursday, October 27th. Shareholders of record on Tuesday, November 15th will be given a dividend of $0.34 per share on Thursday, December 15th. This represents a $1.36 annualized dividend and a yield of 0.60%. The ex-dividend date is Monday, November 14th.
Read our dividend analysis for TFX.

Is Teleflex a good dividend stock?

Teleflex (NYSE:TFX) pays an annual dividend of $1.36 per share and currently has a dividend yield of 0.60%. The dividend payout ratio is 15.60%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, TFX will have a dividend payout ratio of 10.03% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for TFX.

What guidance has Teleflex issued on next quarter's earnings?

Teleflex issued an update on its FY 2022 earnings guidance on Thursday, November, 3rd. The company provided earnings per share (EPS) guidance of $12.80-$13.20 for the period, compared to the consensus estimate of $13.10. The company issued revenue guidance of $2.79 billion-$2.82 billion, compared to the consensus revenue estimate of $2.81 billion.

What is Liam Kelly's approval rating as Teleflex's CEO?

73 employees have rated Teleflex Chief Executive Officer Liam Kelly on Glassdoor.com. Liam Kelly has an approval rating of 86% among the company's employees.

What other stocks do shareholders of Teleflex own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Teleflex investors own include NVIDIA (NVDA), AbbVie (ABBV), Johnson & Johnson (JNJ), Alibaba Group (BABA), Lam Research (LRCX), ServiceNow (NOW), QUALCOMM (QCOM), Advanced Micro Devices (AMD), Salesforce (CRM) and Cisco Systems (CSCO).

What is Teleflex's stock symbol?

Teleflex trades on the New York Stock Exchange (NYSE) under the ticker symbol "TFX."

Who are Teleflex's major shareholders?

Teleflex's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (11.38%), BlackRock Inc. (7.19%), State Street Corp (4.34%), Price T Rowe Associates Inc. MD (3.09%), Ceredex Value Advisors LLC (1.87%) and TD Asset Management Inc. (1.14%). Insiders that own company stock include Andrew A Krakauer, Cameron P Hicks, James J Leyden, John Deren, Liam Kelly, Stephen K MD Klasko, Stephen K MD Klasko and Stuart A Randle.
View institutional ownership trends.

How do I buy shares of Teleflex?

Shares of TFX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Teleflex's stock price today?

One share of TFX stock can currently be purchased for approximately $228.08.

How much money does Teleflex make?

Teleflex (NYSE:TFX) has a market capitalization of $10.70 billion and generates $2.81 billion in revenue each year. The medical technology company earns $485.37 million in net income (profit) each year or $8.72 on an earnings per share basis.

How many employees does Teleflex have?

The company employs 14,000 workers across the globe.

How can I contact Teleflex?

Teleflex's mailing address is 550 E SWEDESFORD RD, WAYNE PA, 19087. The official website for the company is www.teleflex.com. The medical technology company can be reached via phone at (610) 225-6800, via email at shareholder@broadridge.com, or via fax at 215-553-5402.

This page (NYSE:TFX) was last updated on 11/29/2022 by MarketBeat.com Staff